Tech Company Financing Transactions

Lewis and Clark Pharmaceuticals Funding Round

Lewis and Clark Pharmaceuticals closed a $100 thousand financing round on 6/30/2013. Investors included CIT GAP Fund.

Transaction Overview

Announced On
6/30/2013
Transaction Type
Venture Equity
Amount
$100,000
Round
Undisclosed
Investors

CIT GAP Fund (Pete Jobse)

Proceeds Purpose
We are filling a huge market need and CIT's investment will helpmove us down the path to growth and Commercialization

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1180 Seminole Trail 495
Charlottesville, VA 22901
USA
Email Address
Not Recorded
Overview
The company develops adenosine-based pharmaceutical compounds for autoimmune disease.
Profile
Lewis and Clark Pharmaceuticals LinkedIn Company Profile
Social Media
Lewis and Clark Pharmaceuticals Company Twitter Account
Company News
Lewis and Clark Pharmaceuticals News
Facebook
Lewis and Clark Pharmaceuticals on Facebook
YouTube
Lewis and Clark Pharmaceuticals on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Robert Thompson
  Robert  Thompson LinkedIn Profile  Robert  Thompson Twitter Account  Robert  Thompson News  Robert  Thompson on Facebook
Chief Scientific Officer
Larry Rodman
  Larry Rodman LinkedIn Profile  Larry Rodman Twitter Account  Larry Rodman News  Larry Rodman on Facebook


 

 

Browse more venture capital transactions:

Prev: 6/30/2013: Veniti venture capital transaction
Next: 6/30/2013: Medonovo venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to report on every notable VC transaction. VC investment data records on this site are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary